Nanocomposix, Inc.
- UEI
- EVQMBF7KC8P3
- CAGE
- 3ZAN8
- Primary NAICS
- 541713 Research and Development in Nanotechnology
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Website
- nanocomposix.com
- Founded
- 2004
- Employees
- 51-250
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Materials
- Chemicals
- Commodity Chemicals
- SIC code
- 73 Business Services
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | -$960 |
| FY2024 | -$25,025 |
| FY2023 | $30,050 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Grant awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Ceres Nanosciences, Inc. | Manassas, VA | 541713 Research and Development in Nanotechnology |
| Spectradyne LLC | Signal Hill, CA | 334516 Analytical Laboratory Instrument Manufacturing |
| Silver Lake Research Corporation | Irwindale, CA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| DCN Diagnostics | Carlsbad, CA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Scientific Manufacturing | Vail, AZ | — |
About the company
Nanocomposix, Inc. is a manufacturer of engineered nanoparticles that provides precisely engineered and highly characterized nanoparticles to help customers bring nanotechnology enabled products to market. Through past prime federal contract awards, Nanocomposix has provided lateral flow assay devices, gold nanoparticles, and research and development services for biomedical technologies such as HIV vaccines, tuberculosis diagnostics, and cytomegalovirus assays. Major funding agencies have included the Department of Health and Human Services (National Institutes of Health, Food and Drug Administration, Centers for Disease Control and Prevention) and Department of Defense (Army). Several contracts were set aside for small businesses. As a subcontractor, Nanocomposix has produced pilot lots for clinical trials. Through a prime federal grant award from the National Institutes of Health, Nanocomposix developed the first commercial rapid diagnostic test to detect Paragonimus infections.
Quick answers
Is Nanocomposix, Inc. registered in SAM.gov?
Nanocomposix, Inc.'s SAM.gov registration expired on April 28, 2023.
How much has Nanocomposix, Inc. received in federal contracts?
Federal contracts obligated $4,065 to Nanocomposix, Inc. in fiscal years 2023 through 2027.
What is Nanocomposix, Inc.'s most recent federal award?
Nanocomposix, Inc.'s most recent federal contract award is Nanocomposix INC:1166666 [23-000622] (75N92B23P00011), from National Insititue of Arthritis and Musculoskeletal and Skin Diseases (NIH), on December 5, 2022.
On GovTribe
See Nanocomposix, Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors